Childress Capital Advisors’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$618K Sell
6,744
-540
-7% -$47.2K 0.1% 136
2026
Q1
$621K Sell
7,284
-1,128
-13% -$101K 0.11% 132
2025
Q4
$665K Buy
8,412
+4,160
+98% +$326K 0.11% 138
2025
Q3
$340K Buy
4,252
+841
+25% +$71.7K 0.06% 209
2025
Q2
$310K Buy
3,411
+1,197
+54% +$109K 0.08% 182
2025
Q1
$207K Sell
2,214
-214
-9% -$19.2K 0.06% 218
2024
Q4
$221K Buy
2,428
+187
+8% +$17.8K 0.06% 201
2024
Q3
$233K Sell
2,241
-37
-2% -$3.77K 0.06% 205
2024
Q2
$221K Buy
+2,278
New +$210K 0.06% 192
2022
Q4
Sell
-3,055
Closed -$220K 185
2022
Q3
$220K Buy
+3,055
New +$240K 0.09% 155
2022
Q1
Sell
-2,688
Closed -$229K 183
2021
Q4
$229K Buy
+2,688
New +$210K 0.09% 159
2021
Q1
Sell
-838
Closed -$72K 316
2020
Q4
$72K Buy
+838
New +$69.3K 0.04% 182

Other funds holding CL

Childress Capital Advisors's CL Position: Q2 2026 in Review

Childress Capital Advisors reduced its Colgate-Palmolive (CL) stake by 7.4% in Q2 2026, selling an estimated $47.2K and leaving 6,744 shares worth $618K. The position accounts for 0.1% of the portfolio, ranked #136.

Childress Capital Advisors first reported a position in CL in Q4 2020 and has held it in 12 quarters since. The position peaked at $665K in Q4 2025. 2,018 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Childress Capital Advisors held 6,744 shares of Colgate-Palmolive worth $618K as of Q2 2026.
  • Childress Capital Advisors sold 540 Colgate-Palmolive shares in Q2 2026, an estimated $47.2K.
  • Colgate-Palmolive made up 0.1% of Childress Capital Advisors's portfolio in Q2 2026, its #136 holding.
  • Childress Capital Advisors first reported a position in Colgate-Palmolive in Q4 2020 and has held it in 12 quarters since.
  • Childress Capital Advisors's Colgate-Palmolive position peaked at $665K in Q4 2025.
  • 2,018 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Childress Capital Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.